[ad_1]
Professional and in-depth study of "Influenza Detection Device Market – Global Sectoral Analysis, Size, Share, Growth, Trends and Forecasts 2016 – 2024" with the coming years Industry trends, projections of global growth, key players and case studies, review, sharing, size, effect.
''
Influenza, commonly known as influenza, is a contagious respiratory disease caused in humans by influenza A and influenza B. There are three types of influenza viruses, namely A, B and C; among these, the type A virus is the most virulent strain. Type A strains can infect humans as well as animals, while influenza B viruses infect humans only.
Type C viruses are less common and cause mild illness in children. Influenza viruses are RNA viruses and possess two major glycoproteins, namely hemagglutinin (HA) and neuraminidase (NA), targets of antibody detection devices. The flu usually spreads during seasonal epidemics, which result in the deaths of thousands of people each year and millions during epidemics.
– Get a sample Report_ https://www.researchmoz.us/enquiry.php?type=S&repid=1362104
''
According to a report by the World Health Organization, seasonal epidemics around the world cause between 3 and 5 million cases of serious illness, resulting in between 250,000 and 500,000 deaths each year. The currently used influenza detection devices are either class I devices or class II devices. Flu detection devices detect antigens using a labeled specific antibody or they act on the principle of nucleic acid amplification.
In the 20th century, three influenza pandemics were reported, each of these pandemics being caused by new strains of viruses in humans. Fifteen subtypes of influenza virus have been reported, including outbreaks of H1N1, H2N2, H3N2, H5N1, H7N7 and H1N2 have been reported by WHO. In April 2009, a new strain of influenza called A / H1N1 flu or swine flu emerged and consolidated the human avian, swine and avian virus genes. The flu has appeared in the United States, Mexico and several other countries.
According to a report by the World Health Organization, seasonal epidemics around the world cause between 3 and 5 million cases of serious illness, resulting in between 250,000 and 500,000 deaths each year. The currently used influenza detection devices are either class I devices or class II devices. Flu detection devices detect antigens using a labeled specific antibody or they act on the principle of nucleic acid amplification.
In the 20th century, three influenza pandemics were reported, each of these pandemics being caused by new strains of viruses in humans. Fifteen subtypes of influenza virus have been reported, including outbreaks of H1N1, H2N2, H3N2, H5N1, H7N7 and H1N2 have been reported by WHO. In April 2009, a new strain of influenza called A / H1N1 flu or swine flu emerged and consolidated the human avian, swine and avian virus genes. The flu has appeared in the United States, Mexico and several other countries.
The global market for influenza detection devices is segmented according to the type of product, the indication of the disease, the end users and the region. Based on the type of product, the global market for influenza detection devices can be subdivided into rapid influenza tests, direct fluorescent antibody tests, direct fluorescence antibody tests.
These influenza detection devices fall under Class I and Class II devices of the FDA. Influenza detection devices allow diagnosis based on various techniques such as reverse transcription-PCR, ELISA, antibody binding, and electrospray ionization mass spectrometry. Based on the indication of the disease, the market for the influenza detection device is classified into three categories: detection of influenza A virus, influenza A / B virus and RSV virus. Based on end-users, the market is segmented into hospitals, specialty clinics, diagnostic centers, research laboratories and contract research organizations.
A global epidemic of seasonal and pandemic influenza illnesses and the emergence of new influenza viruses increase the risk to public health. The rapid influenza test segment is expected to account for the largest share of the global detection device market. However, the FDA has highlighted the poor performance of the RIPD test during the 2009 pandemic outbreak, which is expected to limit the growth of this segment of the influenza detection device market to some extent. According to CDC estimates, approximately 60.8 million H1N1 cases were reported in the United States in 2009. Thus, based on the indication of the disease, the influenza A segment is expected to experience strong growth. during the forecast period.
– More Clear Details Get Full Table of Contents #Table of Contents
''
The global market for influenza detection devices is divided into five key regions: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Geographically, North America is expected to be an important part of the global market for influenza detection devices. Asia and Europe also represent a significant market share in the market for influenza detection devices and are expected to experience significant growth in the near future. The rapid market growth in these regions is attributed to the increasing prevalence of chronic diseases and the increase in the geriatric population.
Cepheid (USA), Roche Molecular Systems Inc. (USA), Becton, Dickinson and Company (USA), Alere (USA), Meridian Life Sciences (USA), Thermo Fisher Scientific Inc. Fast-track Diagnostics Ltd., R-Biopharm AG, Sekisui Diagnostics, DiaSorin Molecular LLC, Maccura and LifeSign PBM.
Carry on…..Sep 28, 18
About Researchmoz,
ResearchMoz is the most dynamic collection of market research reports in the world. Our database is made up of current market research from more than 100 publishers around the world. Our market research databases integrate statistics and analyzes of global, regional, national and corporate perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping and in-depth surveys by a team of experienced research coordinators.
-Researchmoz Global Pvt. Ltd.-
Mr. Nachiket G.
90 State Street
Albany, NY 12207,
United States,
Tel: 866-997-4948 (toll free Canada-Canada),
Tel: + 1-518-621-2074
www.researchmoz.us
Post Views:
6
Source link
